NM_000081.4:c.10564+43G>A
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000081.4(LYST):c.10564+43G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.482 in 1,571,076 control chromosomes in the GnomAD database, including 195,556 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000081.4 intron
Scores
Clinical Significance
Conservation
Publications
- Chediak-Higashi syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P
- attenuated Chédiak-Higashi syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.532 AC: 80881AN: 152004Hom.: 23439 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.420 AC: 103367AN: 245900 AF XY: 0.412 show subpopulations
GnomAD4 exome AF: 0.477 AC: 676800AN: 1418954Hom.: 172068 Cov.: 23 AF XY: 0.468 AC XY: 331761AN XY: 708282 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.532 AC: 80978AN: 152122Hom.: 23488 Cov.: 32 AF XY: 0.519 AC XY: 38594AN XY: 74356 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:2
This variant is classified as Benign based on local population frequency. This variant was detected in 43% of patients studied by a panel of primary immunodeficiencies. Number of patients: 41. Only high quality variants are reported. -
- -
not provided Benign:2
- -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at